Managers
Monroe Capital has acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the growth of Citizens Rx.
Based in Oak Park, Illinois, Citizens Rx is a full-service Pharmacy Benefit Management provider for public and private companies and health plans. The company provides “unbundled,” modular pharmacy benefit management services, including formulary management, claims processing, rebate administration, and a 67,000-location national pharmacy network.
Schroders has launched ts first UK-dedicated infrastructure debt fund, with a focus on UK pension funds and insurance companies.
The Schroder UK Infrastructure Debt fund will target junior loans in the transport, energy, environmental, social infrastructure and telecoms sectors in the UK, focusing on higher yielding opportunities in the market. Infrastructure debt is an increasingly attractive asset class for institutional investors due to its defensive nature. Junior loans in infrastructure also offer attractive relative value compared to high yield bonds and leveraged loans.
The UK is already one of the largest and most diversified infrastructure markets in Europe, boasting
Impact investment in India topped USD1 billion for the first time in 2015 and, between 2010 and 2016, totalled more than USD5.2 billion as the market attracted more than 50 active impact funds, according to new research by McKinsey.
The new data also reveals that the average deal size has more than doubled (from USD7.6 million in 2010 to USD17.6 million in 2016) while the number of deals has remained stable (at between 60 and 80 a year over the period). Financial inclusion and clean energy projects remain the most attractive sectors for investment, respectively accounting for 43 per cent
Palatine Private Equity has held the Final Close of Palatine Private Equity Impact Investing Fund LP (Impact Fund) at its hard-cap of GBP100 million, exceeding its GBP75 million target. Evercore Private Funds Group acted as the exclusive global placement agent for the fundraise.
The Impact Fund is the inaugural vehicle raised by Palatine targeting a positive social and/or environmental impact alongside industry-standard returns. It represents a continuation of Palatine’s commitment to responsible investing, and builds upon the numerous awards the firm has won for its Environmental, Social and Governance (ESG) credentials.
Beth Houghton, Partner, (pictured) is leading the Fund.
Atlas for Men, the men’s outdoor clothing brand that became independent from Groupe De Agostini a year ago, following a spin-off organized by Activa Capital and the Management team, has refinanced its existing debt alongside an extended pool of banks, allowing the full reimbursement of the mezzanine debt and partial reimbursement of the shareholder funds.
Founded in 1999 within the Groupe De Agostini, Atlas for Men is a specialized men’s outdoor brand for clothing and accessories, sold online and by catalogue. The brand is present in 10 European countries and generates close to EUR160 million in sales from six million
Foresight Group (Foresight) has invested GBP3 million from the Foresight Regional Investment Fund into the specialist engineering company ONFAB Limited, a designer and manufacturer of flexible containment solutions, primarily for use in pharmaceutical manufacturing processes.
ONFAB was founded in 2004 by Oliver Nulty, a former Astra Zeneca engineer, who spotted the market opportunity created by increasing health and safety regulations which made containment a higher priority, specifically in pharmaceutical manufacturing processes. Today, the total global containment market is valued at around GBP320m, with an estimated growth rate of 10-20 per cent per annum.
With Foresight’s investment, ONFAB will continue
Pegasus Solar, a designer and manufacturer of innovative rooftop mounting systems for solar installations, has closed on a Series A round of equity funding led by Ecosystem Integrity Fund (EIF), with additional participation from Okapi Capital, Howard Wenger, Mike Miskovsky, and other solar industry executives.
Pegasus said that it will use the proceeds to grow its sales and customer support teams and to continue its industry-leading efforts to design and manufacture efficient and functional solar mounting systems.
“We are excited to partner with EIF and other investors who share our passion for solar energy and support our mission to
Private equity firm Silverfleet Capital is to acquire Pumpenfabrik Wangen (Wangen), a designer and manufacturer of high quality progressing cavity and twin-screw pumps.
Silverfleet will acquire a majority stake from the Company’s individual private shareholders. Completion is subject to regulatory approval and the terms of the transaction were not disclosed.
Founded in 1969 and based in Wangen, Germany, the Company is a market leader in the manufacture of screw pumps that are suitable for highly viscous or abrasive substances as well as solid-fluid composites. Wangen offers a broad range of standard as well as customised pumps designed and manufactured
InfoSum has added USD5 million to its seed funding, taking the total raised to date to USD8 million.
Joining existing investors Mark Suster (Upfront Ventures) and Roger Ehrenberg (IA Ventures), are Saul Klein (LocalGlobe), and Mike Chalfen (Mosaic Ventures). The additional investment will be used to build the company’s senior management team and bring the company’s first products to market.
InfoSum’s goal is to equip every company with the ability to unlock the commercial potential of thousands of siloed datasets sitting in numerous companies. In doing so it will give every organisation access to the same breadth and depth
Integra LifeSciences Holdings Corporation is to sell certain neurosurgery assets to Natus Medical for USD47.5 million. The divestiture is contingent on the consummation of Integra’s proposed acquisition of Codman Neurosurgery from Johnson & Johnson.
As part of this divestiture, Integra will sell the global Camino® ICP monitoring product line, including its San Diego manufacturing facility, to Natus Medical. The divestiture package also includes certain assets and the US rights relating to Integra’s fixed pressure shunts, as well as US rights to Codman’s DURAFORM®, standard EVD catheters and CSF collection systems.
“This agreement is an important step toward the completion
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
